In contrast, when the focus was narrowed to patients with CRC, the relapse or death rates observed across the sCD40L tertiles were six patients (14.0%) in the lowest sCD40L tertile, thirteen patients (30.2%) in the middle tertile, and seventeen patients (32.7%) in the highest tertile. This evidence concerns the gene CD40LG and colorectal carcinoma.